Synchronous and sequential activation of latently infected Epstein-Barr virus genomes.
about
An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 linkSignal Transduction and Transcription Factor Modification during Reactivation of Epstein-Barr Virus from LatencyEpstein-Barr virus (EBV) SM protein induces and recruits cellular Sp110b to stabilize mRNAs and enhance EBV lytic gene expressionDifferential expression of the miR-200 family microRNAs in epithelial and B cells and regulation of Epstein-Barr virus reactivation by the miR-200 family member miR-429Regulation of the latent-lytic switch in Epstein-Barr virusProtein kinase A associates with HA95 and affects transcriptional coactivation by Epstein-Barr virus nuclear proteins.Regulation of MYC expression and differential JQ1 sensitivity in cancer cellsInhibition of Epstein-Barr virus replication by a benzimidazole L-riboside: novel antiviral mechanism of 5, 6-dichloro-2-(isopropylamino)-1-beta-L-ribofuranosyl-1H-benzimidazole.The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral outputImmediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell responseMta has properties of an RNA export protein and increases cytoplasmic accumulation of Epstein-Barr virus replication gene mRNA.Global transcript structure resolution of high gene density genomes through multi-platform data integrationA molecular link between malaria and Epstein-Barr virus reactivation.Stage-specific inhibition of MHC class I presentation by the Epstein-Barr virus BNLF2a protein during virus lytic cycle.Epstein-Barr virus promotes epithelial cell growth in the absence of EBNA2 and LMP1 expressionKinetics of Kaposi's sarcoma-associated herpesvirus gene expression.A Temporal Proteomic Map of Epstein-Barr Virus Lytic Replication in B Cells.Discovery of small-molecule human immunodeficiency virus type 1 entry inhibitors that target the gp120-binding domain of CD4.Role of Rta in the translation of bicistronic BZLF1 of Epstein-Barr virusActivation of the Epstein-Barr virus transcription factor BZLF1 by 12-O-tetradecanoylphorbol-13-acetate-induced phosphorylation.Activation of the BRLF1 promoter and lytic cycle of Epstein-Barr virus by histone acetylationEpstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinasesHistone acetylation and reactivation of Epstein-Barr virus from latency.Rta of murine gammaherpesvirus 68 reactivates the complete lytic cycle from latency.Hairy leukoplakia: an unusual combination of transforming and permissive Epstein-Barr virus infections.Function of the intercistronic region of BRLF1-BZLF1 bicistronic mRNA in translating the zta protein of Epstein-Barr virus.Cell cycle analysis of Epstein-Barr virus-infected cells following treatment with lytic cycle-inducing agentsEpstein-Barr virus immediate-early protein BRLF1 induces the lytic form of viral replication through a mechanism involving phosphatidylinositol-3 kinase activation.Identification of major phosphorylation sites of Epstein-Barr virus nuclear antigen leader protein (EBNA-LP): ability of EBNA-LP to induce latent membrane protein 1 cooperatively with EBNA-2 is regulated by phosphorylationAutostimulation of the Epstein-Barr virus BRLF1 promoter is mediated through consensus Sp1 and Sp3 binding sites.Control of Epstein-Barr virus reactivation by activated CD40 and viral latent membrane protein 1.The Epstein-Barr virus R transactivator (Rta) contains a complex, potent activation domain with properties different from those of VP16.Epigenetic control of viral life-cycle by a DNA-methylation dependent transcription factor.Epstein-Barr virus mRNA export factor EB2 is essential for intranuclear capsid assembly and production of gp350Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient.Contribution of C/EBP proteins to Epstein-Barr virus lytic gene expression and replication in epithelial cellsProtein kinase C-independent activation of the Epstein-Barr virus lytic cycle.Virus and cell RNAs expressed during Epstein-Barr virus replicationThe nuclear and adherent junction complex component protein ubinuclein negatively regulates the productive cycle of Epstein-Barr virus in epithelial cellsLatent membrane protein 1 inhibits Epstein-Barr virus lytic cycle induction and progress via different mechanisms.
P2860
Q21131584-F14D4E00-11D8-4D2A-892D-D5E00B2DB0E2Q24538669-1E410E17-FB4B-4D75-99CA-31BAB3E306ACQ24562972-7EDECE70-8C47-4C78-9E17-019DF2F524FCQ24619491-1EA63670-6613-4DE1-8F0A-366206076A06Q27021366-620ACFCE-02AE-48A2-A2AD-C732091C94D7Q28114910-9328DA29-499D-476F-933A-E917627AD235Q28306655-150DCB72-8CBA-476F-BDFE-58C7EDD0442DQ28343493-EBE0BFC6-819D-4456-9DE1-78DEDB93C941Q28752465-147933D1-5558-492D-A494-15BF70F62852Q30442835-CC1B194A-A43B-4042-9EE2-AA53BCDDC67CQ30453521-6AF75650-CE25-4F92-BDAF-7F18F5947D18Q31114225-868B6710-9BD5-495C-BD50-40C31216036DQ33287194-23171B3D-D1AB-4178-AE10-DBC7ABB3D414Q33474804-9056FDE1-B29D-4A27-936F-45FDE07F1AAEQ33641167-D0067B6C-8AC3-4FAB-9599-7DFCCF2DF52AQ33653424-F7D7F9A9-B818-4CFE-85EE-18CA3473C25AQ33734376-22E29231-0A88-46F0-ABBD-7B0DC3724E07Q33780620-C25E5577-A2DA-4288-91E1-F14FDC3EE590Q33784597-2B441BA7-739B-4B24-8EC3-867B6A2657B4Q33784820-7905494F-6A71-4D87-8615-6C8A45EB37C4Q33786869-F6D1820C-5891-4BC2-994A-430BBCA16BCCQ33793163-15DF2D0A-CB0D-4CEE-A5EC-F3674F47EA41Q33796114-CF7C31AA-0E6B-4F8A-B9BD-ADE96623D3E0Q33802415-324D87C0-0732-4E97-8C01-1BB163F36332Q33809963-A79F3466-435F-42E1-B07E-612389A2F088Q33836031-F48F09B6-EF7E-4822-9F39-52BAE62BAF51Q33840193-31350B65-58FC-4CAC-9399-721F9E0A6232Q33842581-23373F6E-07CC-4804-BD5A-65BBC9D5603BQ33851767-18CBF5A7-46DF-4548-A0E4-9703AFD9EB65Q33851925-A7621E97-9520-45CD-B7E4-979A2FE2E35AQ33898010-44B9C6E2-B231-452E-80C4-1897A933D571Q33936163-27832C1F-00A7-4B1D-B311-EE85998BD08BQ34055803-C5163D85-B6EE-40B2-A9C2-92A17CFF0345Q34123899-F487EA34-F609-4A52-B020-B421A8A8644EQ34228526-5ACE7620-AE50-453D-837A-B921B7795A1EQ34302078-0C2CB728-1737-4200-A475-39DEA304B312Q34363413-2B5D9541-FFE6-41A8-A1BA-41B0FF8E94FEQ34434702-EC976FAB-FF86-41BC-A838-BF72CE8B5076Q34485205-4B95028C-FC29-4381-9E8B-AD71B003A6E1Q34532370-E47706C8-66A7-405D-BFE0-E2D50AE444E7
P2860
Synchronous and sequential activation of latently infected Epstein-Barr virus genomes.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Synchronous and sequential activation of latently infected Epstein-Barr virus genomes.
@en
type
label
Synchronous and sequential activation of latently infected Epstein-Barr virus genomes.
@en
prefLabel
Synchronous and sequential activation of latently infected Epstein-Barr virus genomes.
@en
P2860
P1433
P1476
Synchronous and sequential activation of latently infected Epstein-Barr virus genomes.
@en
P2860
P304
P407
P577
1989-01-01T00:00:00Z